Archive - March 2019
Celgene hopes for second time lucky for ozanimod FDA filing
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event
EU approves AZ’ Forxiga for type I diabetes
Motif Bio raises £2.7 million via share placing
Tiziana submits IND for Foralumab oral formulation in NASH
Eisai, Biogen move Alzheimer’s treatment into Phase III
Thermo Fisher buys Brammer Bio for $1.7bn
Rituximab found to extend progression-free survival in indolent lymphoma